Conversations with Experts

FDA-Approved Cemiplimab-rwlc is Effective in the Treatment of Patients with Metastatic Cutaneous Squamous Cell...

To provide a comprehensive summary of cemiplimab-rwlc, an FDA-approved therapy used in the treatment of metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC in patients who are not candidates for curative surgery or curative radiation.

Conversations With Experts: Expert Insights into Thyroid Eye Disease

In this interview, Roger A. Dailey, MD, FACS, Lester T Jones Endowed Chair, oculoplastic surgeon and Chief of the Casey Thyroid Eye Disease Clinic, and Terry F. Davies, MBBS, MD, FRCP, FACE, an endocrinologist...

Conversations With Experts: Successful Management of the Patient on NERLYNX® Therapy for...

Overview of NERLYNX® (neratinib) Tablets NERLYNX is a once-daily, oral kinase inhibitor that is ap-proved for extended adjuvant treatment of adult patients with early-stage human epidermal growth factor receptor 2 (HER2)-overexpressed/amplified breast cancer following...

Conversations With Experts: Understanding the Clinical and Economic Burden of Chronic Rhinosinusitis with Nasal...

Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a chronic inflammatory disease that can affect quality of life.
video

VIDEO: Experts Talk Stress Cardiomyopathy in COVID-19

DocWire News hosts a conversation between Cardiology Section Adviser Payal Kohli, MD, and Ankur Kalra,...
A Dual Inhibitor Approach: MEK Inhibitor Plus Defactinib Shows Promise in Eye Cancer

Interview: A Dual Inhibitor Approach Shows Promise in Eye Cancer

Preclinical data suggest that a combined approach to metastatic uveal melanoma may be a viable...
video

Mohammadreza Hojat, PhD, on the Importance of Physician Empathy

Dr. Mohammadreza Hojat, a research professor in the Department of Psychiatry and Human Behavior at...
video

Payal Kohli, MD, on COVID-19, Cardiology, and Lasting Changes

DocWire News sits down with cardiologist Payal Kohli, MD, of Cherry Creek Heart in Denver,...
video

VIDEO: Chip Lavie, MD on ACE Inhibitors and ARBs in Hypertensive COVID-19 Patients

DocWire News interviews Carl J. "Chip" Lavie, MD, of the John Ochsner Heart and Vascular...
video

Efficacy Comparison: DOAC Antidote Versus PCC for Bleeding Management

In this presentation, Jan Beyer-Westendorf, MD, of the Dresden University Clinic in Germany, assesses the...
video

Assessing Strategies for Reversing the Anticoagulant Effect

In this discussion, Adrian Parry-Jones, PhD, MRCP, of The University of Manchester in the United...
direct oral anticoagulantsvideo

James Douketis, MD: Interrupting Direct Oral Anticoagulants for Surgery Is Safe and Effective

James Douketis, MD, McMaster University, Hamilton, Ontario, discusses the the PAUSE (the Perioperative Anticoagulant Use...
iPATH Study and Key Biomarkers that Affect Bleeding Patterns for Hemophilia Avideo

Dr. Peter Turecek: iPATH Study and Key Biomarkers that Affect Bleeding Patterns for Hemophilia A

During the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego...
video

Aziz Nazha, MD: Personalized Approach Improves Survival Prediction in Patients With Myelodysplastic Syndromes

At the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, Aziz Nazha,...
stem cellvideo

Mitchell Cairo, MD: Stem Cell Transplant Improves Outcomes in Sickle Cell Disease

Mitchell Cairo, MD, Chief of Pediatric Hematology, Oncology and Stem Cell Transplantation; Director of the...
video

Richard Maziarz, MD: Tisagenlecleucel Induces Durable Response Among Adults With Pretreated DLBCL

According to updated data from the phase II JULIET trial presented at the 2018 ASH Annual...
video

Omega-3 Fatty Acids Did Not Reduce CV Events or Cancers

Omega-3 fatty acids (found in fish oil supplements) were not associated with a reduction in cardiovascular (CV)...
hematopoietic cell transplantationvideo

Jonathan U. Peled, MD: Disruptions in the Gut Microbiota on Post-Transplantation Outcomes

Jonathan U. Peled, MD, of Memorial Sloan Kettering Cancer Center discusses his study which looked...
gene therapyvideo

Interview: Erica Esrick, MD: Novel Approach to Gene Therapy for Sickle Cell Disease Shows Promise

Erica B. Esrick, MD, Hematologist at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center reported on...
video

Interview: Koen Ameloot, MD, PhD: Results and Analysis of the Neuroprotect Trial

Koen Ameloot, MD, PhD discussed the Neuroprotect trial, which looked at 112 survivors of out-of-hospital...
video

Richard Maziarz, MD: Tisagenlecleucel induces durable response among adults with pretreated DLBCL

Richard Thomas Maziarz, MD discusses the JULIET trial at the American Society of Hematology (ASH)...
video

Viola Poeschel, MD: 4 Cycles of CHOP (Instead of 6) Is Favorable for Diffuse Large B-Cell Lymphoma

Viola Poeschel, MD, presented the results of the phase 3 FLYER trial...
click me
--> -->